Description
PF-06873600 is a selective inhibitor of CDK2/4/6 in multiple in vivo tumor models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
PF-06873600 is a selective inhibitor of CDK2/4/6 in multiple in vivo tumor models.
| Cas No. | 2185857-97-8 |
|---|---|
| Purity | ≥98% |
| Formula | C20H27F2N5O4S |
| Formula Wt. | 471.52 |
| IUPAC Name | 6-(difluoromethyl)-8-[(1R,2R)-2-hydroxy-2-methylcyclopentyl]-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrido[2,3-d]pyrimidin-7-one |
| Synonym | PF06873600, Ebvaciclib |
| Appearance | White powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Freeman-Cook K, Hoffman R, Miller N, et al. Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor. Cancer Cell. 2021 Oct 11;39(10):1404-1421. PMID: 34520734
Jeselsohn R, Schiff R, Grinshpun A. Restoring order at the cell cycle border: co-targeting CDK4/6 and CDK2. Cancer Cell. 2021 Oct 11;39(10):1302-1305. PMID: 34506738
Freeman-Cook K, Hoffman R, Behenna D, et al. Discovery of PF-06873600, a CDK2/4/6 inhibitor for the treatment of cancer. J Med Chem. 2021 Jul 8;64(13):9056-9077. PMID: 34110834
benzophenanthridine alkaloid found in Chelidoni...
TRPC5, NS4B, histamine H1 inhibitor.
Antipruritic.
Phenothiazine derivative; D1/2 and 5-HT1A/2A an...
Alkaloid found in Catharanthus, precursor in sy...
Bisphosphonate; inhibits transfer of farnesyl p...
Loop diuretic; NKCC symporter and KCC2 co-trans...
Endogenous opioid peptide; μOR agonist.
SARS-CoV-2 inhibitor
Peptide deformylase, MMP meprin A, aminopeptida...
NSAID; COX-1/2 inhibitor.
Cysteine derivative, antioxidant, ROS scavenger...
Podophyllotoxin derivative; topoisomerase II in...
β-lactam cephalosporin; penicillin binding pro...
Isoquinoline alkaloid found in a variety of pla...
Endogenous tachykinin peptide, involved in infl...
Macrocycle
Peptide, binds fibronectin.
Endogenous peptide hormone; guanyl cyclase C ag...
H+/K+ ATPase and ROCK-2 inhibitor.